HIGHLIGHTS
- who: Andrea Zovi and colleagues from the Ministry of Health, Viale Giorgio Ribotta, Rome, Italy have published the paper: Pharmacological Agents with Antiviral Activity against Monkeypox Infection, in the Journal: (JOURNAL) of 13/07/2018
- what: Certainly, one of the main reasons why this virus is able to remain active in the wild is that it uses different hosts.
- future: It is noteworthy that the efficacy and adverse events of these antiviral agents have been evaluated in a very limited number of patients and the limited evidence currently available confirms that further studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.